Mycophenolic Acid (Apotex Corp)


Welcome to the PulseAid listing for the Mycophenolic Acid drug offered from Apotex Corp. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotex Corp
NON-PROPRIETARY NAME: Mycophenolic Acid
SUBSTANCE NAME: MYCOPHENOLATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimetabolite Immunosuppressant [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, DELAYED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-08-21
END MARKETING DATE: 0000-00-00


Mycophenolic Acid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMycophenolic Acid from Apotex Corp
LABELER NAME: Apotex Corp
DEA SCHEDULE:
ACTIVE STRENGTH: 180(mg/1)
START MARKETING DATE: 2012-08-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60505-2965_d0b0d1dd-17f3-c02d-bd99-f434e6edd763
PRODUCT NDC: 60505-2965
APPLICATION NUMBER: ANDA091558

Other MYCOPHENOLATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Mycophenolic Acid
American Health PackagingMycophenolic Acid
Apotex CorpMycophenolic Acid
Avera McKennan HospitalMyfortic
Golden State Medical Supply, Inc.Mycophenolic Acid
Novartis Pharmaceuticals CorporationMyfortic